GGI
PYXS icon

GordonMD Global Investments’s Pyxis Oncology PYXS Stock Holding History

GordonMD Global Investments’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2M Buy
10,024,909
+5,903,039
+143% +$11.3M 14.6% 2
2026
Q1 		$6.02M Hold
4,121,870
– – 4.19% 8
2025
Q4 		$4.74M Buy
+4,121,870
New +$14.5M 3.4% 12

Other funds holding PYXS

P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

GordonMD Global Investments's PYXS Position: Q2 2026 in Review

GordonMD Global Investments increased its Pyxis Oncology (PYXS) stake by 143% in Q2 2026, buying an estimated $11.3M and bringing the position to 10,024,909 shares worth $30.2M. The position accounts for 14.6% of the portfolio, ranked #2.

GordonMD Global Investments first reported a position in PYXS in Q4 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • GordonMD Global Investments held 10,024,909 shares of Pyxis Oncology worth $30.2M as of Q2 2026.
  • GordonMD Global Investments bought 5,903,039 Pyxis Oncology shares in Q2 2026, an estimated $11.3M.
  • Pyxis Oncology made up 14.6% of GordonMD Global Investments's portfolio in Q2 2026, its #2 holding.
  • GordonMD Global Investments first reported a position in Pyxis Oncology in Q4 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on GordonMD Global Investments's 13F filing for Q2 2026, filed 14 Aug 2026.